These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 31493764)

  • 1. Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment.
    Xu WH; Xu Y; Wang J; Wan FN; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2019 Sep; 11(17):6999-7020. PubMed ID: 31493764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database.
    Chen B; Chen W; Jin J; Wang X; Cao Y; He Y
    Dis Markers; 2019; 2019():8901649. PubMed ID: 31781309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of an immune-related prognostic model by exploring the tumor microenvironment of clear cell renal cell carcinoma.
    He J; Zhong Y; Sun Y; Xie C; Yu T
    Anal Biochem; 2022 Apr; 643():114567. PubMed ID: 35122734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
    Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
    Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
    Wan B; Liu B; Huang Y; Lv C
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma.
    Zhang Z; Li Z; Liu Z; Zhang X; Yu N; Xu Z
    J Cell Biochem; 2020 Jul; 121(7):3606-3615. PubMed ID: 31961022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
    Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Key Genes of Prognostic Value in Clear Cell Renal Cell Carcinoma Microenvironment and a Risk Score Prognostic Model.
    Zhao E; Bai X
    Dis Markers; 2020; 2020():8852388. PubMed ID: 32952743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
    Hu D; Zhou M; Zhu X
    Biomed Res Int; 2019; 2019():2506843. PubMed ID: 31886185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
    Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
    Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
    Xu C; Zeng H; Fan J; Huang W; Yu X; Li S; Wang F; Long X
    BMC Cancer; 2022 Mar; 22(1):264. PubMed ID: 35279104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC).
    Liu S; Li S; Wang Y; Wang F; Zhang L; Xian S; Yang D; Yuan M; Dai F; Zhao X; Liu Y; Jin Y; Zeng Z; Mahgoub OKA; Zhou C; Cheng Y
    J Cell Biochem; 2020 Mar; 121(3):2571-2581. PubMed ID: 31823423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
    Ghatalia P; Gordetsky J; Kuo F; Dulaimi E; Cai KQ; Devarajan K; Bae S; Naik G; Chan TA; Uzzo R; Hakimi AA; Sonpavde G; Plimack E
    J Immunother Cancer; 2019 May; 7(1):139. PubMed ID: 31138299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma.
    Hua S; Xie Z; Zhang Y; Wu L; Shi F; Wang X; Xia S; Dong S; Jiang J
    Front Immunol; 2022; 13():869297. PubMed ID: 35936012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential biomarkers associated with immune infiltration in papillary renal cell carcinoma.
    Deng R; Li J; Zhao H; Zou Z; Man J; Cao J; Yang L
    J Clin Lab Anal; 2021 Nov; 35(11):e24022. PubMed ID: 34606125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
    Zeng Q; Zhang W; Li X; Lai J; Li Z
    Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas.
    Wang Z; Zhu L; Li K; Sun Y; Giamas G; Stebbing J; Peng L; Yu Z
    Cancer Gene Ther; 2022 Oct; 29(10):1418-1428. PubMed ID: 35370291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma.
    Gu YY; Chen G; Lin P; Cheng JW; Huang ZG; Luo J; Zhai GQ; Wang YL; Yan HB; Li SH
    Cancer Biomark; 2020; 27(2):265-275. PubMed ID: 31929144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.